St. Louis VC firm RiverVest closes on $74m second fund

The Missouri biotech-focussed firm has beaten its previous fund by $30m.

4 January 2013•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.